Autres langues Zenith Capital Corp.

Actions

ZHCLF

CA98935N1033

Temps Différé OTC Markets Autres places de cotation 19:33:54 24/04/2024			Varia. 5j.	Varia. 1 janv.
0,2 ^USD	-13,04 %		+11,11 %	+66,67 %

05/04	Zenith Capital Corp. annonce ses résultats pour le troisième trimestre et les neuf mois terminés le 31 janvier 2024	CI
2023	Zenith Capital Corp. annonce ses résultats pour le deuxième trimestre et le semestre clos le 31 octobre 2023	CI

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Zenith Capital Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended January 31, 2024	05/04
Zenith Capital Corp. Reports Earnings Results for the Second Quarter and Six Months Ended October 31, 2023	23/12
Zenith Capital Corp. Reports Earnings Results for the First Quarter Ended July 31, 2023	28/09/23
Zenith Capital Corp. Reports Earnings Results for the Full Year Ended April 30, 2023	29/08/23
Zenith's Bet Inhibitor ZEN-3694 Providing Significant Clinical Benefit in Patients with Aggressive Cancer Type	01/06/23
Zenith Capital Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended January 31, 2023	06/04/23
Zenith Capital Corp. Reports Earnings Results for the Second Quarter and Six Months Ended October 31, 2022	24/12/22
Zenith Capital Corp. Reports Earnings Results for the First Quarter Ended July 31, 2022	30/09/22
Zenith Capital Corp. Auditor Raises 'Going Concern' Doubt	15/09/22
Zenith Capital Corp. Reports Earnings Results for the Full Year Ended April 30, 2022	15/09/22
Zenith Epigenetics Announces Initiation of Phase 2b Triple Negative Breast Cancer Clinical Trial	10/05/22
Zenith Capital Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended January 31, 2022	01/04/22
Zenith Epigenetics Provides Clinical Update	31/01/22
Zenith Epigenetics Announces Changes to Board of Directors	31/01/22
Zenith Capital Corp. Reports Earnings Results for the Second Quarter and Six Months Ended October 31, 2021	20/12/21
Newsoara BioPharma Co., Ltd. announced that it expects to receive $1.5 million in funding from Zenith Capital Corp.	15/11/21
Zenith Capital Corp. Reports Earnings Results for the Full Year Ended April 30, 2021	31/08/21
Zenith Capital Corp. Auditor Raises 'Going Concern' Doubt	30/08/21
Zenith Epigenetics Announces a Publication Highlighting the Role of ZEN-3694 in Overcoming Resistance to Therapies in Metastatic Castration-Resistant Prostate Cancer	24/06/21
Zenith Epigenetics Announces Clinical Collaboration with Astellas	22/04/21

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Zenith Capital Corp.

Actions

ZHCLF

CA98935N1033

Autres langues

Filtres